Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Daily News

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Yael L. Maxwell

April 22, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Daily News

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

Todd Neale

July 04, 2017

News Daily News

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Todd Neale

June 05, 2017

News Daily News

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Michael O'Riordan

April 07, 2017

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

L.A. McKeown

August 11, 2016

News Conference News EAS 2016

Better Knowledge of Sex-Specific Differences in CV Risk Factors and Symptoms Could Save Lives, Improve Care

Yael L. Maxwell

June 02, 2016

Advertisement

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Early Coronary Function Testing Improves Quality of Life in ANOCA

May 2025 Dispatch for the CV Team

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Better Knowledge of Sex-Specific Differences in CV Risk Factors and Symptoms Could Save Lives, Improve Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content